These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18890575)

  • 1. Five year end-results in uterine, ovarian and breast cancer; patients treated in 1942 at Thomas D. Dee Memorial Hospital.
    MILLS EP
    Miss Valley Med J; 1948 Nov; 70(6):222. PubMed ID: 18890575
    [No Abstract]   [Full Text] [Related]  

  • 2. Five-year end results in uterine, ovarian and breast cancer; report on female genital cancers treated in 1943 at the Thomas D. Dee Memorial Hospital.
    MILLS EP
    Miss Valley Med J; 1949 Nov; 71(6):218. PubMed ID: 15407967
    [No Abstract]   [Full Text] [Related]  

  • 3. [A report on cancer of uterine cervix, uterine body, ovaries and breast in young women].
    STROBEL E; STROBEL-TREUTER S
    Krebsarzt; 1956 Aug; 11(4):197-204. PubMed ID: 13377638
    [No Abstract]   [Full Text] [Related]  

  • 4. Risk of cancer after use of fertility drugs with in-vitro fertilisation.
    Venn A; Watson L; Bruinsma F; Giles G; Healy D
    Lancet; 1999 Nov; 354(9190):1586-90. PubMed ID: 10560672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Report on female genital carcinoma treated in 1946; a five-year follow-up at the Thomas D. Dee Memorial Hospital, with two cases at St. Benedict's, both of Ogden, Utah.
    MILLS EP
    Miss Valley Med J; 1952 Nov; 74(6):168-9. PubMed ID: 13013132
    [No Abstract]   [Full Text] [Related]  

  • 6. Progesterone in the treatment of advanced malignant tumours of breast, ovary and uterus.
    JOLLES B
    Br J Cancer; 1962 Jun; 16(2):209-21. PubMed ID: 14452177
    [No Abstract]   [Full Text] [Related]  

  • 7. [Genital carcinoma and ovary].
    HUBER H
    Arch Gynakol; 1953; 183():457-69. PubMed ID: 13125466
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metallothionein expression in normal endometrium and cancers of the uterus, ovary and breast].
    Schmid KW; Hittmair A; Tötsch M; Müller E; Zaimet A; Tauscher T; Dünser M; Ofner D
    Gynakol Rundsch; 1990; 30 Suppl 1():150-1. PubMed ID: 2079251
    [No Abstract]   [Full Text] [Related]  

  • 9. A nationwide population-based retrospective cohort study of the risk of uterine, ovarian and breast cancer in women with polycystic ovary syndrome.
    Shen CC; Yang AC; Hung JH; Hu LY; Tsai SJ
    Oncologist; 2015 Jan; 20(1):45-9. PubMed ID: 25410097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Uterine and ovarian metastases 28 years after the discovery of breast cancer].
    Mohseni H; Truong P; Hadjseyd M; Grimonpont A; Dieny A; Mechin-Cretinon I; Chabert P
    Presse Med; 2003 Jan; 32(2):67-9. PubMed ID: 12653028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The incidence of alcohol intolerance in women with tumours of the uterus, ovary or breast.
    Brewin TB
    Proc R Soc Med; 1967 Dec; 60(12):1308-9. PubMed ID: 6066581
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood-group incidence (ABO system) in patients with mammary, ovarian and uterine neoplasms].
    CUTRERA A; LEONI R
    Riv Ostet Ginecol; 1959 Nov; 14():737-44. PubMed ID: 13813454
    [No Abstract]   [Full Text] [Related]  

  • 13. Age-specific breast, uterine and ovarian cancer mortality trends in Spain: changes from 1980 to 2006.
    Cabanes A; Vidal E; Pérez-Gómez B; Aragonés N; López-Abente G; Pollán M
    Cancer Epidemiol; 2009 Oct; 33(3-4):169-75. PubMed ID: 19766076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history.
    Nelson CL; Sellers TA; Rich SS; Potter JD; McGovern PG; Kushi LH
    Genet Epidemiol; 1993; 10(4):235-44. PubMed ID: 8224804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A consideration of some uterine and ovarian tumors.
    CURTIS AH
    West J Surg Obstet Gynecol; 1948 Jul; 56(7):404-6. PubMed ID: 18872876
    [No Abstract]   [Full Text] [Related]  

  • 16. [Synthesis bulletin of 2005 surveillance. Clinical practice recommendations: the use of PET-FDG in cancers of the breast, ovary and uterus].
    Bourguet P; Hitzel A; Houvenaeghel G; Vinatier D; Bosquet L; Bonichon F; Corone C; Giard-Lefèvre S; Morett JL; Touboul E; ; ; ; ; ; ; ;
    Bull Cancer; 2006 Apr; 93(4):385-90. PubMed ID: 16714228
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis of uterine and ovarian cancer.
    TRAUT HF
    Postgrad Med; 1955 Jun; 17(6):469-71. PubMed ID: 14384625
    [No Abstract]   [Full Text] [Related]  

  • 18. Mortality predictions for Ireland, 2001-2015: cancers of the breast, ovary, and cervix and Corpus uteri.
    O'Lorcain P; Comber H
    Int J Gynecol Cancer; 2006; 16 Suppl 1():1-10. PubMed ID: 16515560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second cancer following cancer of the female genital system in Connecticut, 1935-82.
    Curtis RE; Hoover RN; Kleinerman RA; Harvey EB
    Natl Cancer Inst Monogr; 1985 Dec; 68():113-37. PubMed ID: 4088293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study.
    Shen CC; Hu LY; Yang AC; Chiang YY; Hung JH; Tsai SJ
    BMC Cancer; 2016 Nov; 16(1):839. PubMed ID: 27809870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.